missing translation for 'onlineSavingsMsg'
Learn More

LYVE1, clone: ALY7, eBioscience™

Rat Monoclonal Antibody

Marke:  Affymetrix eBioscience 14-0443-82

Weitere Details : Gewicht : 0.01000kg

 Weitere Artikel aus diesem Sortiment

Artikelnummer. 15296957

  • 180.00 € / 100 Mikrogramm


Auf Lager: 3
Zum Warenkorb hinzufügen

Beschreibung

Beschreibung

This can be used at less than or equal to 0.125 μg per million cells in a 100 μL total staining volume for flow cytometry and 2.5 μg/mL for immunofluorescent micoscopy. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Purity: Greater than 90%, as determined by SDS-PAGE. Aggregation: Less than 10%, as determined by HPLC. Filtration: 0.2 μm post-manufacturing filtered. LYVE1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluro) on the lymph vessel wall. The deduced amino acid sequence of LYVE1 predicts a 322-residue type I integral membrane polypeptide 41% similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module, the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE1 molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE1 molecule colocalizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves. LYVE1 is a type I integral membrane glycoprotein. LYVE-1 is expressed primarily on lymphatic vessel endothelium and is likely to be involved in regulating the traffic of leucocytes and tumor cells to lymph nodes. The lymphatic vasculature forms a second circulatory system that drains extracellular fluid from the tissues and provides an exclusive environment in which immune cells can encounter and respond to foreign antigen. A number of molecules have been identified as markers for lymphatic endothelium which include LYVE1, PALE, VEGFR3, and podoplanin. Diseases associated with LYVE1 dysfunction includes Complete Androgen Insensitivity Syndrome.
Spezifikation

Spezifikation

LYVE1
Monoclonal
0.5 mg/mL
PBS with 0.09% sodium azide; pH 7.2
Q8BHC0
Extracellular link domain containing 1, HAR, hyaluronic acid receptor, lymphatic vessel endothelial hyaluro receptor 1, LYVE-1, XLKD1
Rat
Affinity chromatography
RUO
Antibody
Monoclonal
Mouse
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Frozen)
ALY7
Unconjugated
Lyve1
Liquid
Lyve1
IgG1, kappa
100 μg
4° C
Primary
114332
Videos

For Research Use Only.